Security key
747324101
Pyxis Oncology, Inc. - Common Stock, par value $0.001 per share (PYXS)
CUSIP: 747324101
Q4 2021 13F Holders as of 31 Dec 2021
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Total 13F shares
- 18,338,628
- Total 13F value
- $199,903,000
- Share change
- +18,328,628
- SEC-reported price per share
- $10.97
- Number of holders
- 51
- Value change
- +$199,792,959
- Number of buys
- 50
- Shares outstanding
- 62,130,557
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2021
Institutions
51
Top holders
10
PYXS full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2022
Pyxis Oncology, Inc. SEC filings
Pyxis Oncology, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 747324101
Recent filing periods:
Ownership snapshot
Top reported holders of PYXS - Pyxis Oncology, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Bayer World Investments B.V.
Disclosed value leader
Bayer World Investments B.V.
Comparable rows
0/4
Latest evidence
13 Oct 2021
3/4/5
Highest disclosed value: $3,839,273
4 rows are not safely comparable across share classes.
Quick read
Bayer World Investments B.V. has the largest disclosed position value at $3.84M.
0 of 4 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Bayer World Investments B.V.'s linked filing trail.
Disclosed position value
Top 4
Bayer World Investments B.V.
$3.84M
Cormorant Asset Management, LP
$1.57M
Ronald Herbst
$234.8K
Ritu Shah
$120K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-4 of 4 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Bayer World Investments B.V. |
3/4/5
Former 10% Owner
|
—
class O/S missing
|
$3,839,273
2,742,338 shares
|
— | 13 Oct 2021 |
| Cormorant Asset Management, LP |
3/4/5
Former 10% Owner
|
—
class O/S missing
|
$1,566,396
1,118,854 shares
|
— | 13 Oct 2021 |
| Ronald Herbst |
3/4/5
Chief Scientific Officer
|
—
mixed-class rows
|
$234,796
118,674 shares
mixed-class rows
|
— | 07 Oct 2021 |
| Ritu Shah |
3/4/5
Chief Operating Officer
|
—
class O/S missing
|
$120,048
31,344 shares
|
— | 07 Oct 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2021
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
51
Shares
18,338,628
Rows available
51
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2021 vs Q4 2025 Across Filers
Q4 2025 holders
78
Q4 2021 holders
51
Holder diff
-27
| Investor | Q4 2025 Shares | Q4 2021 Shares | Share Diff | Share Chg % | Q4 2025 value | Q4 2021 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend